Raymond F. Vennare, Director at Predictive Oncology Inc. (POAI), bought 5,000 shares at $0.52 ($3K) on 2022-12-02, disclosed to the SEC on 2022-12-02.
Open-market purchase of $3k POAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.52 | 400 | $208 | 8.0% |
| 2 | $0.52 | 4,600 | $2K | 92.0% |
| Total | $0.52 avg | 5,000 | $3K | 100% |